Journal of Clinical Medicine
Longitudinal Changes in Serum Interleukin-33 Levels During Acute Psychotic Relapse and Clinical Improvement in Schizophrenia: An Admission-Discharge Study
By A.M. Morera, José Juan Tascón-Cervera, Estefania Diaz-Mesa and 3 others.
Abstract
Background/Objectives: Schizophrenia pathophysiology has been linked to immune dysregulation, but the role of interleukin-33 (IL-33) during acute psychotic relapse remains insufficiently investigated. This exploratory admission–discharge study aimed to evaluate serum IL-33 levels in inpatients with paranoid schizophrenia and in healthy controls.